What amount sold does Avidon Health LLC report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Avidon Health LLC's most recent SEC filing?

Avidon Health LLC's most recent Form D filing was on 2022-03-25.

How many investors does Avidon Health LLC have?

The most recent Form D filing lists 33 investor(s).

What type of securities does Avidon Health LLC offer?

Avidon Health LLC's SEC Form D filings indicate equity offerings.

Avidon Health LLC

CIK: 0001918548·Other Health Care·CRANFORD, NJ·Limited Liability Company

Reported Sold

Total Filings

Identified Offerings

Last Filed

Mar 25, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Mar 25, 2022Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·33 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1,000,001 - $5,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Lagemann Clark

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 25, 2022	New	Indefinite	$0	33

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

SURGICAL CENTER OF SOUTH JERSEY LP

Other Health Care

Offering target: $1,120,499

Filed Oct 8, 2026